ONTOLOGY REPORT - ANNOTATIONS
| Term: | cell cycle arrest |
|
| Accession: | GO:0007050
|
browse the term
|
| Definition: | A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M). |
| Synonyms: | exact_synonym: | arrest of cell cycle progression; cessation of cell cycle; termination of cell cycle |
| | xref_analog: | Reactome:REACT_104854; Reactome:REACT_110745; Reactome:REACT_21387; Reactome:REACT_34173; Reactome:REACT_34536; Reactome:REACT_78416; Reactome:REACT_78593; Reactome:REACT_79397; Reactome:REACT_80257; Reactome:REACT_80760; Reactome:REACT_81821; Reactome:REACT_84630; Reactome:REACT_86872; Reactome:REACT_90070; Reactome:REACT_90301; Reactome:REACT_92874; Reactome:REACT_92909 |
|
|
cell cycle arrest
|
| G |
Ak1 |
adenylate kinase 1 |
|
|
ISO |
2 |
19,821,482 |
19,822,544 |
RGD:1624291 |
RGD |
| G |
Apbb1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
|
|
ISO |
1 |
163,282,918 |
163,299,333 |
RGD:1624291 |
RGD |
| G |
Apbb1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
|
|
IEA |
1 |
163,282,918 |
163,299,333 |
RGD:1600115 |
ENSEMBL |
| G |
Apbb1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
|
|
ISS |
1 |
163,282,918 |
163,299,333 |
RGD:1600115 |
UniProtKB |
| G |
Apbb2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
|
|
ISO |
14 |
44,197,568 |
44,526,047 |
RGD:1624291 |
RGD |
| G |
Apc |
adenomatous polyposis coli |
|
|
ISO |
18 |
26,732,147 |
26,790,383 |
RGD:1624291 |
RGD |
| G |
Apc |
adenomatous polyposis coli |
|
|
IEA |
18 |
26,732,147 |
26,790,383 |
RGD:1600115 |
InterPro |
| G |
Apc |
adenomatous polyposis coli |
|
|
ISS |
18 |
26,732,147 |
26,790,383 |
RGD:1600115 |
UniProtKB |
| G |
Atm |
ataxia telangiectasia mutated |
|
|
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:1624291 |
RGD |
| G |
Atm |
ataxia telangiectasia mutated |
|
|
IEA |
8 |
56,894,746 |
56,996,565 |
RGD:1600115 |
ENSEMBL |
| G |
Bmyc |
brain expressed myelocytomatosis oncogene |
|
|
IEA |
3 |
3,864,740 |
3,865,499 |
RGD:1600115 |
ENSEMBL |
| G |
Calr |
calreticulin |
|
|
ISO |
19 |
24,964,775 |
24,969,670 |
RGD:1624291 |
RGD |
| G |
Calr |
calreticulin |
|
|
IEA |
19 |
24,964,775 |
24,969,670 |
RGD:1600115 |
ENSEMBL |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
|
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:1624291 |
RGD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
|
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:1624291 |
RGD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
|
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:1624291 |
RGD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
|
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:1624291 |
RGD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
|
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:1624291 |
RGD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
|
IEA |
1 |
203,835,215 |
203,837,844 |
RGD:1600115 |
InterPro |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
|
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:1624291 |
RGD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
|
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:1624291 |
RGD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
|
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:1624291 |
RGD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
|
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:1624291 |
RGD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
|
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:1624291 |
RGD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
|
IEA |
5 |
108,939,669 |
108,945,293 |
RGD:1600115 |
ENSEMBL |
| G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
|
ISO |
5 |
131,012,524 |
131,017,679 |
RGD:1624291 |
RGD |
| G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
|
IEA |
5 |
131,012,524 |
131,017,679 |
RGD:1600115 |
ENSEMBL |
| G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
|
IEA |
15 |
22,617,409 |
22,624,922 |
RGD:1600115 |
ENSEMBL |
| G |
Cgref1 |
cell growth regulator with EF hand domain 1 |
|
|
IEA |
6 |
25,414,812 |
25,426,818 |
RGD:1600115 |
UniProtKB |
| G |
Cgrrf1 |
cell growth regulator with ring finger domain 1 |
|
|
IEA |
15 |
22,683,387 |
22,703,833 |
RGD:1600115 |
UniProtKB |
| G |
Commd5 |
COMM domain containing 5 |
|
|
IDA |
7 |
114,949,725 |
114,951,149 |
RGD:632845 |
RGD |
| G |
Dbc1 |
deleted in bladder cancer 1 |
|
|
IEA |
5 |
86,070,267 |
86,216,181 |
RGD:1600115 |
UniProtKB |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
|
IEA |
7 |
67,247,749 |
67,252,571 |
RGD:1600115 |
UniProtKB |
| G |
Dst |
dystonin |
|
|
IEA |
9 |
32,757,554 |
33,051,275 |
RGD:1600115 |
InterPro |
| G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
|
ISO |
10 |
95,794,488 |
95,855,895 |
RGD:1624291 |
RGD |
| G |
Ern2 |
endoplasmic reticulum to nucleus signaling 2 |
|
|
ISO |
1 |
181,012,795 |
181,029,728 |
RGD:1624291 |
RGD |
| G |
Ern2 |
endoplasmic reticulum to nucleus signaling 2 |
|
|
IEA |
1 |
181,012,795 |
181,029,728 |
RGD:1600115 |
ENSEMBL |
| G |
Foxo4 |
forkhead box O4 |
|
|
ISO |
X |
89,332,278 |
89,338,835 |
RGD:1624291 |
RGD |
| G |
Foxo4 |
forkhead box O4 |
|
|
IEA |
X |
89,332,278 |
89,338,835 |
RGD:1600115 |
ENSEMBL |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
|
IEA |
4 |
96,649,941 |
96,652,243 |
RGD:1600115 |
UniProtKB |
| G |
Gas2 |
growth arrest-specific 2 |
|
|
IEA |
1 |
101,697,265 |
101,798,495 |
RGD:1600115 |
InterPro |
| G |
Gas2l1 |
growth arrest-specific 2 like 1 |
|
|
IEA |
14 |
85,716,617 |
85,726,368 |
RGD:1600115 |
InterPro |
| G |
Gas2l2 |
growth arrest-specific 2 like 2 |
|
|
IEA |
10 |
71,505,385 |
71,512,429 |
RGD:1600115 |
InterPro |
| G |
Gas2l3 |
growth arrest-specific 2 like 3 |
|
|
IEA |
7 |
26,150,699 |
26,170,382 |
RGD:1600115 |
InterPro |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
|
ISO |
1 |
201,385,705 |
201,388,987 |
RGD:1624291 |
RGD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
|
ISO |
1 |
201,385,705 |
201,388,987 |
RGD:1624291 |
RGD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
|
IEA |
1 |
201,385,705 |
201,388,987 |
RGD:1600115 |
ENSEMBL |
| G |
Ifng |
interferon gamma |
|
|
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:1624291 |
RGD |
| G |
Ifng |
interferon gamma |
|
|
IEA |
7 |
57,621,756 |
57,625,792 |
RGD:1600115 |
ENSEMBL |
| G |
Il12a |
interleukin 12A |
|
|
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:1624291 |
RGD |
| G |
Il12a |
interleukin 12A |
|
|
IEA |
2 |
158,710,261 |
158,717,689 |
RGD:1600115 |
ENSEMBL |
| G |
Il12b |
interleukin 12B |
|
|
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:1624291 |
RGD |
| G |
Ilk |
integrin-linked kinase |
|
|
IMP |
1 |
163,481,299 |
163,487,550 |
RGD:2301768 |
RGD |
| G |
Ing4 |
inhibitor of growth family, member 4 |
|
|
IEA |
4 |
161,161,044 |
161,169,603 |
RGD:1600115 |
ENSEMBL |
| G |
Ing4 |
inhibitor of growth family, member 4 |
|
|
ISO |
4 |
161,161,044 |
161,169,603 |
RGD:1624291 |
RGD |
| G |
Inhba |
inhibin beta-A |
|
|
ISO |
17 |
57,244,466 |
57,257,531 |
RGD:1624291 |
RGD |
| G |
Inhba |
inhibin beta-A |
|
|
ISS |
17 |
57,244,466 |
57,257,531 |
RGD:1600115 |
UniProtKB |
| G |
Irf1 |
interferon regulatory factor 1 |
|
|
ISO |
10 |
39,220,600 |
39,227,602 |
RGD:1624291 |
RGD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
|
ISS |
10 |
39,220,600 |
39,227,602 |
RGD:1600115 |
UniProtKB |
| G |
Irf1 |
interferon regulatory factor 1 |
|
|
IEA |
10 |
39,220,600 |
39,227,602 |
RGD:1600115 |
ENSEMBL |
| G |
Irf6 |
interferon regulatory factor 6 |
|
|
ISO |
13 |
108,986,973 |
109,006,180 |
RGD:1624291 |
RGD |
| G |
Irf6 |
interferon regulatory factor 6 |
|
|
IEA |
13 |
108,986,973 |
109,006,180 |
RGD:1600115 |
ENSEMBL |
| G |
LOC680875 |
similar to dystonin isoform 1 |
|
|
IEA |
7 |
114,153,257 |
114,161,638 |
RGD:1600115 |
InterPro |
| G |
Macf1 |
microtubule-actin crosslinking factor 1 |
|
|
IEA |
5 |
142,659,726 |
142,986,873 |
RGD:1600115 |
InterPro |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
|
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:1624291 |
RGD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
|
IEA |
8 |
68,379,074 |
68,451,554 |
RGD:1600115 |
ENSEMBL |
| G |
Men1 |
multiple endocrine neoplasia I |
|
|
ISO |
1 |
209,114,987 |
209,120,837 |
RGD:1624291 |
RGD |
| G |
Mfn2 |
mitofusin 2 |
|
|
IDA |
5 |
164,951,252 |
164,980,763 |
RGD:1304351 |
UniProtKB |
| G |
Mlf1 |
myeloid leukemia factor 1 |
|
|
IEA |
2 |
157,230,783 |
157,263,847 |
RGD:1600115 |
ENSEMBL |
| G |
Mlf1 |
myeloid leukemia factor 1 |
|
|
ISO |
2 |
157,230,783 |
157,263,847 |
RGD:1624291 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
IEA |
6 |
11,199,906 |
11,258,350 |
RGD:1600115 |
ENSEMBL |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:1624291 |
RGD |
| G |
Myc |
myelocytomatosis oncogene |
|
|
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:1624291 |
RGD |
| G |
Notch2 |
notch 2 |
|
|
ISO |
2 |
192,839,350 |
192,986,589 |
RGD:1624291 |
RGD |
| G |
Notch2 |
notch 2 |
|
|
IEA |
2 |
192,839,350 |
192,986,589 |
RGD:1600115 |
ENSEMBL |
| G |
Notch2 |
notch 2 |
|
|
ISS |
2 |
192,839,350 |
192,986,589 |
RGD:1600115 |
UniProtKB |
| G |
Pcbp4 |
poly(rC) binding protein 4 |
|
|
ISO |
8 |
111,597,539 |
111,607,775 |
RGD:1624291 |
RGD |
| G |
Pkd1 |
polycystic kidney disease 1 homolog (human) |
|
|
ISO |
10 |
13,801,445 |
13,848,212 |
RGD:1624291 |
RGD |
| G |
Pkd2 |
polycystic kidney disease 2 (autosomal dominant) |
|
|
ISO |
14 |
6,349,519 |
6,392,988 |
RGD:1624291 |
RGD |
| G |
Pkd2 |
polycystic kidney disease 2 (autosomal dominant) |
|
|
IEA |
14 |
6,349,519 |
6,392,988 |
RGD:1600115 |
ENSEMBL |
| G |
Pml |
promyelocytic leukemia |
|
|
ISO |
8 |
62,020,438 |
62,051,927 |
RGD:1624291 |
RGD |
| G |
Pml |
promyelocytic leukemia |
|
|
ISO |
8 |
62,020,438 |
62,051,927 |
RGD:1624291 |
RGD |
| G |
Pml |
promyelocytic leukemia |
|
|
ISO |
8 |
62,020,438 |
62,051,927 |
RGD:1624291 |
RGD |
| G |
Pmp22 |
peripheral myelin protein 22 |
|
|
IEA |
10 |
49,305,835 |
49,335,864 |
RGD:1600115 |
UniProtKB |
| G |
Ppm1g |
protein phosphatase, Mg2+/Mn2+ dependent, 1G |
|
|
ISO |
6 |
25,145,569 |
25,149,811 |
RGD:1624291 |
RGD |
| G |
Ppm1g |
protein phosphatase, Mg2+/Mn2+ dependent, 1G |
|
|
IEA |
6 |
25,145,569 |
25,149,811 |
RGD:1600115 |
ENSEMBL |
| G |
Rassf1 |
Ras association (RalGDS/AF-6) domain family member 1 |
|
|
ISO |
8 |
112,798,863 |
112,810,004 |
RGD:1624291 |
RGD |
| G |
Rassf1 |
Ras association (RalGDS/AF-6) domain family member 1 |
|
|
IEA |
8 |
112,798,863 |
112,810,004 |
RGD:1600115 |
ENSEMBL |
| G |
Rb1 |
retinoblastoma 1 |
|
|
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:1624291 |
RGD |
| G |
Rb1 |
retinoblastoma 1 |
|
|
IEA |
15 |
53,828,881 |
53,962,099 |
RGD:1600115 |
ENSEMBL |
| G |
Rbm38 |
RNA binding motif protein 38 |
|
|
IEA |
3 |
163,885,488 |
163,898,314 |
RGD:1600115 |
ENSEMBL |
| G |
Rprm |
reprimo, TP53 dependent G2 arrest mediator candidate |
|
|
ISO |
3 |
35,590,166 |
35,591,583 |
RGD:1624291 |
RGD |
| G |
Rprm |
reprimo, TP53 dependent G2 arrest mediator candidate |
|
|
IEA |
3 |
35,590,166 |
35,591,583 |
RGD:1600115 |
ENSEMBL |
| G |
Sesn1 |
sestrin 1 |
|
|
IEA |
20 |
45,786,623 |
45,877,856 |
RGD:1600115 |
InterPro |
| G |
Sesn2 |
sestrin 2 |
|
|
IEA |
5 |
152,639,951 |
152,655,828 |
RGD:1600115 |
InterPro |
| G |
Sesn3 |
sestrin 3 |
|
|
IEA |
8 |
11,076,055 |
11,125,523 |
RGD:1600115 |
InterPro |
| G |
Sgsm3 |
small G protein signaling modulator 3 |
|
|
IEA |
7 |
119,259,355 |
119,306,023 |
RGD:1600115 |
UniProtKB |
| G |
Skil |
SKI-like oncogene |
|
|
ISO |
2 |
116,669,375 |
116,691,472 |
RGD:1624291 |
RGD |
| G |
Skil |
SKI-like oncogene |
|
|
IEA |
2 |
116,669,375 |
116,691,472 |
RGD:1600115 |
ENSEMBL |
| G |
Slfn1 |
schlafen 1 |
|
|
ISO |
10 |
71,264,746 |
71,265,762 |
RGD:1624291 |
RGD |
| G |
Smad3 |
SMAD family member 3 |
|
|
ISO |
8 |
67,803,909 |
67,952,056 |
RGD:1624291 |
RGD |
| G |
Smad3 |
SMAD family member 3 |
|
|
IEA |
8 |
67,803,909 |
67,952,056 |
RGD:1600115 |
ENSEMBL |
| G |
Sox2 |
SRY (sex determining region Y)-box 2 |
|
|
ISO |
2 |
120,969,021 |
120,971,430 |
RGD:1624291 |
RGD |
| G |
Sox2 |
SRY (sex determining region Y)-box 2 |
|
|
IEA |
2 |
120,969,021 |
120,971,430 |
RGD:1600115 |
ENSEMBL |
| G |
Stk11 |
serine/threonine kinase 11 |
|
|
IEA |
7 |
11,086,760 |
11,103,522 |
RGD:1600115 |
ENSEMBL |
| G |
Stk11 |
serine/threonine kinase 11 |
|
|
ISO |
7 |
11,086,760 |
11,103,522 |
RGD:1624291 |
RGD |
| G |
Stk11 |
serine/threonine kinase 11 |
|
|
ISO |
7 |
11,086,760 |
11,103,522 |
RGD:1624291 |
RGD |
| G |
Tbrg1 |
transforming growth factor beta regulator 1 |
|
|
ISO |
8 |
38,890,730 |
38,898,388 |
RGD:1624291 |
RGD |
| G |
Tcf7l2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
|
|
ISO |
1 |
262,031,823 |
262,226,710 |
RGD:1624291 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:1624291 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:1600115 |
UniProtKB |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
|
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:1624291 |
RGD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
|
IEA |
13 |
102,718,703 |
102,818,768 |
RGD:1600115 |
ENSEMBL |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
|
ISS |
13 |
102,718,703 |
102,818,768 |
RGD:1600115 |
UniProtKB |
| G |
Thbs1 |
thrombospondin 1 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Tp53 |
tumor protein p53 |
|
|
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:1624291 |
RGD |
| G |
Tp53 |
tumor protein p53 |
|
|
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:1624291 |
RGD |
| G |
Tp53 |
tumor protein p53 |
|
|
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:1624291 |
RGD |
| G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
|
|
ISO |
5 |
25,008,253 |
25,014,263 |
RGD:1624291 |
RGD |
| G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
|
|
IEA |
5 |
25,008,253 |
25,014,263 |
RGD:1600115 |
ENSEMBL |
| G |
Tp73 |
tumor protein p73 |
|
|
ISO |
5 |
170,848,979 |
171,078,739 |
RGD:1624291 |
RGD |
| G |
Tp73 |
tumor protein p73 |
|
|
IEA |
5 |
170,848,979 |
171,078,739 |
RGD:1600115 |
ENSEMBL |
| G |
Tsg101 |
tumor susceptibility gene 101 |
|
|
ISO |
1 |
97,445,040 |
97,475,141 |
RGD:1624291 |
RGD |
| G |
Uhmk1 |
U2AF homology motif (UHM) kinase 1 |
|
|
ISO |
13 |
86,010,861 |
86,025,965 |
RGD:1624291 |
RGD |
| G |
Uhmk1 |
U2AF homology motif (UHM) kinase 1 |
|
|
IEA |
13 |
86,010,861 |
86,025,965 |
RGD:1600115 |
ENSEMBL |
| G |
Wdr6 |
WD repeat domain 6 |
|
|
ISO |
8 |
113,618,341 |
113,624,757 |
RGD:1624291 |
RGD |
| G |
Wdr6 |
WD repeat domain 6 |
|
|
IEA |
8 |
113,618,341 |
113,624,757 |
RGD:1600115 |
ENSEMBL |
| G |
Wnt10b |
wingless-type MMTV integration site family, member 10B |
|
|
ISO |
7 |
137,541,197 |
137,547,000 |
RGD:1624291 |
RGD |
| G |
Zak |
sterile alpha motif and leucine zipper containing kinase AZK |
|
|
ISO |
3 |
54,767,724 |
54,915,022 |
RGD:1624291 |
RGD |
| G |
Zfhx3 |
zinc finger homeobox 3 |
|
|
IEP |
19 |
38,547,428 |
38,783,613 |
RGD:1625359 |
RGD |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest
|
| G |
Casp2 |
caspase 2 |
|
|
ISO |
4 |
70,029,728 |
70,047,164 |
RGD:1624291 |
RGD |
| G |
Casp2 |
caspase 2 |
|
|
IEA |
4 |
70,029,728 |
70,047,164 |
RGD:1600115 |
ENSEMBL |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
|
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:1624291 |
RGD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
|
IEA |
20 |
7,376,325 |
7,386,778 |
RGD:1600115 |
ENSEMBL |
| G |
Cradd |
CASP2 and RIPK1 domain containing adaptor with death domain |
|
|
IEA |
7 |
32,504,279 |
32,517,581 |
RGD:1600115 |
ENSEMBL |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
|
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:1624291 |
RGD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
|
IEA |
7 |
56,996,694 |
57,020,926 |
RGD:1600115 |
ENSEMBL |
| G |
Muc1 |
mucin 1, cell surface associated |
|
|
ISO |
2 |
181,399,482 |
181,403,640 |
RGD:1624291 |
RGD |
| G |
Pcbp4 |
poly(rC) binding protein 4 |
|
|
ISO |
8 |
111,597,539 |
111,607,775 |
RGD:1624291 |
RGD |
| G |
Pidd |
p53-induced death domain protein |
|
|
ISO |
1 |
201,626,042 |
201,631,182 |
RGD:1624291 |
RGD |
| G |
Pml |
promyelocytic leukemia |
|
|
ISO |
8 |
62,020,438 |
62,051,927 |
RGD:1624291 |
RGD |
| G |
Ppp2r5c |
protein phosphatase 2, regulatory subunit B', gamma |
|
|
ISO |
6 |
135,204,405 |
135,299,068 |
RGD:1624291 |
RGD |
| G |
Ptprv |
protein tyrosine phosphatase, receptor type, V |
|
|
ISO |
13 |
48,070,488 |
48,090,682 |
RGD:1624291 |
RGD |
| G |
Rbm38 |
RNA binding motif protein 38 |
|
|
IEA |
3 |
163,885,488 |
163,898,314 |
RGD:1600115 |
ENSEMBL |
| G |
Sox4 |
SRY (sex determining region Y)-box 4 |
|
|
ISO |
17 |
42,172,863 |
42,177,590 |
RGD:1624291 |
RGD |
| G |
Tp53 |
tumor protein p53 |
|
|
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:1624291 |
RGD |
mitotic cell cycle arrest
|
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
|
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:1624291 |
RGD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
|
IEA |
20 |
7,376,325 |
7,386,778 |
RGD:1600115 |
ENSEMBL |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
|
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:1624291 |
RGD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
|
IEA |
4 |
171,841,705 |
171,846,506 |
RGD:1600115 |
ENSEMBL |
| G |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
|
|
IDA |
4 |
9,909,448 |
11,441,301 |
|
UniProtKB |
| G |
Nkx3-1 |
NK3 homeobox 1 |
|
|
ISO |
15 |
49,743,313 |
49,745,905 |
RGD:1624291 |
RGD |
| G |
Nkx3-1 |
NK3 homeobox 1 |
|
|
IEA |
15 |
49,743,313 |
49,745,905 |
RGD:1600115 |
ENSEMBL |
| G |
Pnpt1 |
polyribonucleotide nucleotidyltransferase 1 |
|
|
IEA |
14 |
110,130,417 |
110,161,762 |
RGD:1600115 |
ENSEMBL |
| G |
Pnpt1 |
polyribonucleotide nucleotidyltransferase 1 |
|
|
ISO |
14 |
110,130,417 |
110,161,762 |
RGD:1624291 |
RGD |
| G |
Rgcc |
regulator of cell cycle |
|
|
ISO |
15 |
60,451,831 |
60,452,229 |
RGD:1624291 |
RGD |
| G |
Rgcc |
regulator of cell cycle |
|
|
IEA |
15 |
60,451,831 |
60,452,229 |
RGD:1600115 |
ENSEMBL |
| G |
RGD1559690 |
similar to hypothetical protein FLJ25416 |
|
|
ISO |
1 |
149,685,954 |
149,710,264 |
RGD:1624291 |
RGD |
| G |
RGD1559690 |
similar to hypothetical protein FLJ25416 |
|
|
IEA |
1 |
149,685,954 |
149,710,264 |
RGD:1600115 |
ENSEMBL |
| G |
Tp53 |
tumor protein p53 |
|
|
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:1624291 |
RGD |
negative regulation of cell cycle arrest
|
| G |
Ccnk |
cyclin K |
|
|
IEA |
6 |
132,547,058 |
132,569,679 |
RGD:1600115 |
ENSEMBL |
| G |
Ccnk |
cyclin K |
|
|
ISO |
6 |
132,547,058 |
132,569,679 |
RGD:1624291 |
RGD |
| G |
Cdk9 |
cyclin-dependent kinase 9 |
|
|
ISO |
3 |
11,672,861 |
11,677,709 |
RGD:1624291 |
RGD |
| G |
Cdk9 |
cyclin-dependent kinase 9 |
|
|
IEA |
3 |
11,672,861 |
11,677,709 |
RGD:1600115 |
ENSEMBL |
| G |
Fgf10 |
fibroblast growth factor 10 |
|
|
ISO |
2 |
50,866,799 |
50,940,319 |
RGD:1624291 |
RGD |
| G |
Fgf10 |
fibroblast growth factor 10 |
|
|
IEA |
2 |
50,866,799 |
50,940,319 |
RGD:1600115 |
ENSEMBL |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
|
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:1624291 |
RGD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
|
IEA |
7 |
56,996,694 |
57,020,926 |
RGD:1600115 |
InterPro |
| G |
Mdm4 |
Mdm4 p53 binding protein homolog (mouse) |
|
|
IEA |
13 |
45,895,832 |
45,931,421 |
RGD:1600115 |
InterPro |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
|
ISO |
20 |
13,191,986 |
13,192,851 |
RGD:1624291 |
RGD |
| G |
Mlxipl |
MLX interacting protein-like |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Rassf1 |
Ras association (RalGDS/AF-6) domain family member 1 |
|
|
ISO |
8 |
112,798,863 |
112,810,004 |
RGD:1624291 |
RGD |
| G |
Rassf1 |
Ras association (RalGDS/AF-6) domain family member 1 |
|
|
IEA |
8 |
112,798,863 |
112,810,004 |
RGD:1600115 |
ENSEMBL |
| G |
Tfap4 |
transcription factor AP-4 |
|
|
IEA |
10 |
11,144,057 |
11,159,763 |
RGD:1600115 |
ENSEMBL |
| G |
Tfap4 |
transcription factor AP-4 |
|
|
ISO |
10 |
11,144,057 |
11,159,763 |
RGD:1624291 |
RGD |
positive regulation of cell cycle arrest
|
| G |
Brca1 |
breast cancer 1, early onset |
|
|
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:1624291 |
RGD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
|
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:1624291 |
RGD |
| G |
Dab2ip |
DAB2 interacting protein |
|
|
ISO |
3 |
14,667,700 |
14,840,625 |
RGD:1624291 |
RGD |
| G |
Dab2ip |
DAB2 interacting protein |
|
|
ISS |
3 |
14,667,700 |
14,840,625 |
RGD:1600115 |
UniProtKB |
| G |
Gata6 |
GATA binding protein 6 |
|
|
ISO |
18 |
2,504,264 |
2,534,648 |
RGD:1624291 |
RGD |
| G |
Hmga2 |
high mobility group AT-hook 2 |
|
|
ISO |
7 |
59,638,555 |
59,753,791 |
RGD:1624291 |
RGD |
| G |
Hmga2 |
high mobility group AT-hook 2 |
|
|
ISS |
7 |
59,638,555 |
59,753,791 |
RGD:1600115 |
UniProtKB |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
|
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:1624291 |
RGD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
|
ISS |
6 |
42,781,476 |
42,783,307 |
RGD:1600115 |
UniProtKB |
| G |
LOC100909468 |
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform-like |
|
|
IDA |
|
|
|
|
MGI |
| G |
Med25 |
mediator complex subunit 25 |
|
|
IEA |
1 |
95,351,526 |
95,364,403 |
RGD:1600115 |
ENSEMBL |
| G |
Med25 |
mediator complex subunit 25 |
|
|
ISO |
1 |
95,351,526 |
95,364,403 |
RGD:1624291 |
RGD |
| G |
Mybbp1a |
MYB binding protein (P160) 1a |
|
|
IEA |
10 |
59,325,648 |
59,335,604 |
RGD:1600115 |
ENSEMBL |
| G |
Mybbp1a |
MYB binding protein (P160) 1a |
|
|
ISO |
10 |
59,325,648 |
59,335,604 |
RGD:1624291 |
RGD |
| G |
Pkd2 |
polycystic kidney disease 2 (autosomal dominant) |
|
|
ISO |
14 |
6,349,519 |
6,392,988 |
RGD:1624291 |
RGD |
| G |
Pkd2 |
polycystic kidney disease 2 (autosomal dominant) |
|
|
IEA |
14 |
6,349,519 |
6,392,988 |
RGD:1600115 |
ENSEMBL |
| G |
Ppp2r5b |
protein phosphatase 2, regulatory subunit B', beta |
|
|
IDA |
1 |
209,002,579 |
209,009,757 |
|
MGI |
| G |
Prkaca |
protein kinase, cAMP-dependent, catalytic, alpha |
|
|
IEA |
19 |
25,840,795 |
25,864,786 |
RGD:1600115 |
ENSEMBL |
| G |
Prkaca |
protein kinase, cAMP-dependent, catalytic, alpha |
|
|
ISO |
19 |
25,840,795 |
25,864,786 |
RGD:1624291 |
RGD |
| G |
Rgcc |
regulator of cell cycle |
|
|
ISO |
15 |
60,451,831 |
60,452,229 |
RGD:1624291 |
RGD |
| G |
Rgcc |
regulator of cell cycle |
|
|
IEA |
15 |
60,451,831 |
60,452,229 |
RGD:1600115 |
ENSEMBL |
| G |
Rrp8 |
ribosomal RNA processing 8, methyltransferase, homolog (yeast) |
|
|
ISO |
1 |
163,477,028 |
163,481,051 |
RGD:1624291 |
RGD |
| G |
Rrp8 |
ribosomal RNA processing 8, methyltransferase, homolog (yeast) |
|
|
IEA |
1 |
163,477,028 |
163,481,051 |
RGD:1600115 |
ENSEMBL |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:1624291 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
IEA |
1 |
80,894,705 |
80,911,020 |
RGD:1600115 |
ENSEMBL |
| G |
Tp53 |
tumor protein p53 |
|
|
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:1624291 |
RGD |
| G |
Uhrf2 |
ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase |
|
|
IEA |
1 |
233,777,723 |
233,841,343 |
RGD:1600115 |
ENSEMBL |
| G |
Uhrf2 |
ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase |
|
|
ISO |
1 |
233,777,723 |
233,841,343 |
RGD:1624291 |
RGD |
regulation of cell cycle arrest
|
| G |
Foxm1 |
forkhead box M1 |
|
|
IEA |
4 |
165,383,666 |
165,394,688 |
RGD:1600115 |
ENSEMBL |
| G |
Foxm1 |
forkhead box M1 |
|
|
ISO |
4 |
165,383,666 |
165,394,688 |
RGD:1624291 |
RGD |
| G |
Foxm1 |
forkhead box M1 |
|
|
IBA |
4 |
165,383,666 |
165,394,688 |
RGD:1600115 |
RefGenome |
| G |
Neurod1 |
neuronal differentiation 1 |
|
|
ISO |
3 |
62,224,633 |
62,227,936 |
RGD:1624291 |
RGD |
| G |
Neurod1 |
neuronal differentiation 1 |
|
|
ISS |
3 |
62,224,633 |
62,227,936 |
RGD:1600115 |
UniProtKB |
Term paths to the root
|